Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker BNGO
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | AIGH Capital Management LLC | 1.17M | 9.9% | SCHEDULE 13G ↗ |
| Oct 19, 2026 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Orin Hirschman | 1.17M | 9.9% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Heights Capital Management, Inc. | 1.31M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | CVI Investments, Inc. | 1.31M | 9.9% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Heights Capital Management, Inc. | 1.13M | 9.9% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | CVI Investments, Inc. | 1.13M | 9.9% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Jeff Easton | 1.05M | 9.3% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Lind Global Partners III LLC | 1.05M | 9.3% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Lind Global Fund III LP | 1.05M | 9.3% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Kimberly Page | 57,200 | 3.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Richard Abbe | 98,944 | 5.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Iroquois Capital Management, LLC | 57,200 | 3.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Kimberly Page | 509,658 | 5.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Richard Abbe | 509,658 | 5.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Iroquois Capital Management, LLC | 509,658 | 5.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Jeff Easton | 514,338 | 9.9% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Lind Global Partners III LLC | 514,338 | 9.9% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Lind Global Fund III LP | 514,338 | 9.9% | SCHEDULE 13G/A ↗ |
| Nov 13, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Waqas Khatri | 528,245 | 10.0% | SCHEDULE 13G ↗ |
| Nov 13, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 528,245 | 10.0% | SCHEDULE 13G ↗ |
| Nov 13, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Ayrton Capital LLC | 528,245 | 10.0% | SCHEDULE 13G ↗ |
| Sep 24, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Jeff Easton | 1.01M | 9.9% | SCHEDULE 13G ↗ |
| Sep 24, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Lind Global Partners III LLC | 1.01M | 9.9% | SCHEDULE 13G ↗ |
| Sep 24, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Lind Global Fund III LP | 1.01M | 9.9% | SCHEDULE 13G ↗ |
| Sep 22, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Heights Capital Management, Inc. | 1.02M | 9.9% | SCHEDULE 13G ↗ |
| Sep 22, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | CVI Investments, Inc. | 1.02M | 9.9% | SCHEDULE 13G ↗ |
| Sep 19, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Intracoastal Capital LLC | 508,415 | 5.0% | SCHEDULE 13G ↗ |
| Sep 19, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Daniel B. Asher | 508,415 | 5.0% | SCHEDULE 13G ↗ |
| Sep 19, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Mitchell P. Kopin | 508,415 | 5.0% | SCHEDULE 13G ↗ |
| Sep 18, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Kimberly Page | 367,500 | 3.8% | SCHEDULE 13G ↗ |
| Sep 18, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Richard Abbe | 525,000 | 5.4% | SCHEDULE 13G ↗ |
| Sep 18, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Iroquois Capital Management, LLC | 367,500 | 3.8% | SCHEDULE 13G ↗ |
| Sep 17, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Lincoln Alternative Strategies LLC | 525,000 | 5.4% | SCHEDULE 13G ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | Heights Capital Management, Inc. | 157,930 | 4.9% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | BNGO Bionano Genomics, Inc. | CVI Investments, Inc. | 157,930 | 4.9% | SCHEDULE 13G/A ↗ |
| Jan 13, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | Heights Capital Management, Inc. | 10.70M | 7.7% | SCHEDULE 13G ↗ |
| Jan 13, 2025 | SCHEDULE 13G | BNGO Bionano Genomics, Inc. | CVI Investments, Inc. | 10.70M | 7.7% | SCHEDULE 13G ↗ |
37 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 8:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances